Bioporto A/S logo

BIOPOR - Bioporto A/S News Story

DKK3.98 0.0  0.4%

Last Trade - 3:59pm

Sector
Industrials
Size
Small Cap
Market Cap £122.8m
Enterprise Value £113.9m
Revenue £2.84m
Position in Universe 842nd / 1828

BRIEF-BioPorto Q3 EBIT Loss Widens To DKK 11.5 Million

Thu 8th November, 2018 7:58am
Nov 8 (Reuters) - BioPorto A/S  BIOPOR.CO :
    * REG-INTERIM REPORT, THIRD QUARTER 2018, BIOPORTO GROUP
    * FDA CLEARANCE OF NGAL TEST EXPECTED BY MID-2019
    * OUTLOOK FOR 2018 MAINTAINED
    * PLANS TO INITIATE A CLINICAL STUDY WITH 150-200 ADDITIONAL PATIENTS
    * Q3 REVENUE DKK 5.4 MILLION VERSUS DKK 6.0 MILLION YEAR AGO
    * Q3 EBIT LOSS DKK 11.5 MILLION VERSUS LOSS DKK 10.7  MILLION YEAR AGO

Source text for Eikon:  ID:nGNE98h1zK 
Further company coverage:  BIOPOR.CO 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.